Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (41)
Sanjay J. Mathew, Shedly Jean-Lys, Rupinder Phull & Rama Yarasani. (2023) Characterization of Extended-Release Lorazepam. Journal of Clinical Psychopharmacology 43:4, pages 350-360.
Crossref
Crossref
Zhi-Kun Qiu, Xu Liu, Yong Chen, Rong-Jia Wu, Shi-Feng Guan, Yun-yun Pan, Qian-Bo Wang, Dan Tang, Tao Zhu & Ji-Sheng Chen. (2020) Translocator protein 18 kDa: a potential therapeutic biomarker for post traumatic stress disorder. Metabolic Brain Disease 35:5, pages 695-707.
Crossref
Crossref
Rowan P Ogeil, Katrina Witt, Deborah Scott, Karen Smith & Dan I Lubman. (2020) Self-reported sleep disturbance in ambulance attendances for suicidal ideation and attempted suicide between 2012 and 2017. Journal of Affective Disorders 265, pages 364-371.
Crossref
Crossref
S.M. Ahmad & J.M.F. Nogueira. (2019) High throughput bar adsorptive microextraction: A novel cost-effective tool for monitoring benzodiazepines in large number of biological samples. Talanta 199, pages 195-202.
Crossref
Crossref
Daniela Curado, Viviam Barros, Emérita Opaleye, Sarah Bowen, Helena Hachul & Ana Regina Noto. (2018) The Role of Mindfulness in the Insomnia Severity of Female Chronic Hypnotic Users. International Journal of Behavioral Medicine 25:5, pages 526-531.
Crossref
Crossref
K.R. Methuku, X. Li, R. Cerne, S.D. Gleason, J.M. Schkeryantz, V.V.N.P.B. Tiruveedhula, L.K. Golani, G. Li, M.M. Poe, Md.T. Rahman, J.M. Cook, J.L. Fisher & J.M. Witkin. (2018) An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA A receptors. Pharmacology Biochemistry and Behavior 170, pages 9-13.
Crossref
Crossref
J.M. Witkin, J.L. Smith, X. Ping, S.D. Gleason, M.M. Poe, G. Li, X. Jin, J. Hobbs, J.M. Schkeryantz, J.S. McDermott, A.I. Alatorre, J.N. Siemian, J.W. Cramer, D.C. Airey, K.R. Methuku, V.V.N.P.B. Tiruveedhula, T.M. Jones, J. Crawford, M.J. Krambis, J.L. Fisher, J.M. Cook & R. Cerne. (2018) Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4 H -benzo[ f ]imidazo [1,5- a ][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA A receptors: improved bioavailability enhances anticonvulsant efficacy. Neuropharmacology.
Crossref
Crossref
J.M. Witkin, R. Cerne, M. Wakulchik, J. S.S.D. Gleason, T.M. Jones, G. Li, L.A. Arnold, J.-X. Li, J.M. Schkeryantz, K.R. Methuku, J.M. Cook & M.M. Poe. (2017) Further evaluation of the potential anxiolytic activity of imidazo[1,5- a ][1,4]diazepin agents selective for ?2/3-containing GABA A receptors. Pharmacology Biochemistry and Behavior 157, pages 35-40.
Crossref
Crossref
Sheng-Min Wang, Jung-Bum Kim, Jeong Kyu Sakong, Ho-Suk Suh, Kang Seob Oh, Jong-Min Woo, Sang-Woo Yoo, Sang Min Lee, Sang-Yeol Lee, Se-Won Lim, Seong Jin Cho, Ik-Seung Chee, Jeong-Ho Chae, Jin Pyo Hong & Kyoung-Uk Lee. (2016) The Efficacy and Safety of Clonazepam in Patients with Anxiety Disorder Taking Newer Antidepressants: A Multicenter Naturalistic Study. Clinical Psychopharmacology and Neuroscience 14:2, pages 177-183.
Crossref
Crossref
Michael Liebrenz, Marie-Therese Gehring, Anna Buadze & Carlo Caflisch. (2015) High-dose benzodiazepine dependence: a qualitative study of patients’ perception on cessation and withdrawal. BMC Psychiatry 15:1.
Crossref
Crossref
Татјана Петрушевска. (2015) Употреба на бензодијазепини кај пациенти на метадонски третман. Macedonian Medical Electronic Journal 1:1, pages 1-262.
Crossref
Crossref
Ryan F Yoshimura, Minhtam B Tran, Derk J Hogenkamp, Timothy B Johnstone, Jennifer Y Xie, Frank Porreca & Kelvin W Gee. (2013)
Limited central side effects of a ?-subunit subtype-selective GABA
A
receptor allosteric modulator
. Journal of Psychopharmacology 28:5, pages 472-478.
Crossref
Crossref
Bernardo Dell'Osso, Giulia Camuri, Beatrice Benatti, Massimiliano Buoli & A. Carlo Altamura. (2013) Differences in latency to first pharmacological treatment (duration of untreated illness) in anxiety disorders: a study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder. Early Intervention in Psychiatry 7:4, pages 374-380.
Crossref
Crossref
Ariel Berger, John Edelsberg, Michael Treglia, Jose Ma J Alvir & Gerry Oster. (2012) Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry 12:1.
Crossref
Crossref
Lindsey I. Sinclair & David J. Nutt. 2012. Neurobiology of Psychiatric Disorders. Neurobiology of Psychiatric Disorders
669
679
.
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
75
94
.
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
55
74
.
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
235
254
.
Ariel Berger, John Edelsberg, Vamsi Bollu, Jose Ma J Alvir, Ashish Dugar, Ashish V Joshi & Gerry Oster. (2011) Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry 11:1.
Crossref
Crossref
Barbara Taferner, Wolfgang Schuehly, Antje Huefner, Igor Baburin, Katharina Wiesner, Gerhard F. Ecker & Steffen Hering. (2011)
Modulation of GABA
A
-Receptors by Honokiol and Derivatives: Subtype Selectivity and Structure–Activity Relationship
. Journal of Medicinal Chemistry 54:15, pages 5349-5361.
Crossref
Crossref
Melissa A. Birkett, Nina M. Shinday, Eileen J. Kessler, Jerrold S. Meyer, Sarah Ritchie & James K. Rowlett. (2011) Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. Pharmacology Biochemistry and Behavior 98:4, pages 544-551.
Crossref
Crossref
Xinzhou Yang, Igor Baburin, Inken Plitzko, Steffen Hering & Matthias Hamburger. (2011) HPLC-based activity profiling for GABAA receptor modulators from the traditional Chinese herbal drug Kushen (Sophora flavescens root). Molecular Diversity 15:2, pages 361-372.
Crossref
Crossref
Alesha J Smith & Susan E Tett. (2010) Improving the use of benzodiazepines-Is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Services Research 10:1.
Crossref
Crossref
Xiaodong F. Liu, Hui-Fang Chang, Richard Jon Schmiesing, Steven S. Wesolowski, Katharine S. Knappenberger, Jeffrey L. Arriza & Marc J. Chapdelaine. (2010) Developing dual functional allosteric modulators of GABAA receptors. Bioorganic & Medicinal Chemistry 18:23, pages 8374-8382.
Crossref
Crossref
Alfredo Carlo Altamura, Massimiliano Buoli, Alessandra Albano & Bernardo DellʼOsso. (2010) Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study. International Clinical Psychopharmacology 25:3, pages 172-179.
Crossref
Crossref
Ryan F Yoshimura, Minhtam B Tran, Derk J Hogenkamp, Timothy B Johnstone & Kelvin W Gee. (2010)
Reduced side effect liability of novel β‐subunit selective GABA
A
receptor allosteric modulators
. The FASEB Journal 24:S1.
Crossref
Crossref
Janine Zaugg, Igor Baburin, Barbara Strommer, Hyun-Jung Kim, Steffen Hering & Matthias Hamburger. (2010)
HPLC-Based Activity Profiling: Discovery of Piperine as a Positive GABA
A
Receptor Modulator Targeting a Benzodiazepine-Independent Binding Site
. Journal of Natural Products 73:2, pages 185-191.
Crossref
Crossref
John R. Atack. 2010. GABA and Sleep. GABA and Sleep
25
72
.
Alessandro Serretti, Alberto Chiesa, Raffaella Calati, Giampaolo Perna, Laura Bellodi & Diana De Ronchi. (2009) Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. International Clinical Psychopharmacology 24:1, pages 1-18.
Crossref
Crossref
Alesha J Smith, Ingrid Sketris, Charmaine Cooke, David Gardner, Steve Kisely & Susan E Tett. (2008) A Comparison of Benzodiazepine and Related Drug Use in Nova Scotia and Australia. The Canadian Journal of Psychiatry 53:8, pages 545-552.
Crossref
Crossref
J. Riss, J. Cloyd, J. Gates & S. Collins. (2008) Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurologica Scandinavica 118:2, pages 69-86.
Crossref
Crossref
Alesha J Smith, Ingrid Sketris, Charmaine Cooke, David Gardner, Steve Kisely & Susan E Tett. (2008) A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiology and Drug Safety 17:7, pages 697-706.
Crossref
Crossref
Mark H. Pollack, Jane Tiller, Fang Xie & Madhukar H. Trivedi. (2008) Tiagabine in Adult Patients With Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology 28:3, pages 308-316.
Crossref
Crossref
H. -P. Kapfhammer. 2008. Psychiatrie und Psychotherapie. Psychiatrie und Psychotherapie
1569
1633
.
Jeffrey A. Wilken & Cynthia Sullivan. (2007) Recognizing and Treating Common Psychiatric Disorders in Multiple Sclerosis. The Neurologist 13:6, pages 343-354.
Crossref
Crossref
George Andrew Michael, Elisabeth Bacon & Isabelle Offerlin-Meyer. (2006) Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias. Journal of Psychopharmacology 21:7, pages 691-699.
Crossref
Crossref
Lindsey Sinclair & David Nutt. (2007) Anxiolytics. Psychiatry 6:7, pages 284-288.
Crossref
Crossref
Elisabeth Bacon, Bennett L. Schwartz, Laurence Paire-Ficout & Marie Izaute. (2007) Dissociation between the cognitive process and the phenomenological experience of TOT: Effect of the anxiolytic drug lorazepam on TOT states. Consciousness and Cognition 16:2, pages 360-373.
Crossref
Crossref
John C. Earnheart, Claude Schweizer, Florence Crestani, Takuji Iwasato, Shigeyoshi Itohara, Hanns Mohler & Bernhard Lüscher. (2007) GABAergic Control of Adult Hippocampal Neurogenesis in Relation to Behavior Indicative of Trait Anxiety and Depression States. The Journal of Neuroscience 27:14, pages 3845-3854.
Crossref
Crossref
Cheng-Fang Yen, Chun-Ya Kuo, Pei-Tzu Tsai, Chih-Hung Ko, Ju-Yu Yen & Tzu-Ting Chen. (2007) Correlations of quality of life with adverse effects of medication, social support, course of illness, psychopathology, and demographic characteristics in patients with panic disorder. Depression and Anxiety 24:8, pages 563-570.
Crossref
Crossref
Samir Ahboucha, Leanne Coyne, Ryoko Hirakawa, Roger F. Butterworth & Robert F. Halliwell. (2006) An interaction between benzodiazepines and neuroactive steroids at GABAA receptors in cultured hippocampal neurons. Neurochemistry International 48:8, pages 703-707.
Crossref
Crossref